These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 34671263)

  • 1. New Challenges Resulting From the Loss of Function of Na
    Nicole S; Lory P
    Front Pharmacol; 2021; 12():751095. PubMed ID: 34671263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of Resurgent Na
    Huang CW; Lai HJ; Lin PC; Lee MJ
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32276507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Molecular Spectrum of Myotonia and Periodic Paralyses Associated With Mutations in
    Maggi L; Brugnoni R; Canioni E; Tonin P; Saletti V; Sola P; Piccinelli SC; Colleoni L; Ferrigno P; Pini A; Masson R; Manganelli F; Lietti D; Vercelli L; Ricci G; Bruno C; Tasca G; Pizzuti A; Padovani A; Fusco C; Pegoraro E; Ruggiero L; Ravaglia S; Siciliano G; Morandi L; Dubbioso R; Mongini T; Filosto M; Tramacere I; Mantegazza R; Bernasconi P
    Front Neurol; 2020; 11():646. PubMed ID: 32849172
    [No Abstract]   [Full Text] [Related]  

  • 4. Sodium Channelopathies of Skeletal Muscle.
    Cannon SC
    Handb Exp Pharmacol; 2018; 246():309-330. PubMed ID: 28939973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita.
    Ke Q; Ye J; Tang S; Wang J; Luo B; Ji F; Zhang X; Yu Y; Cheng X; Li Y
    J Physiol; 2017 Nov; 595(22):6837-6850. PubMed ID: 28940424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy.
    Zaharieva IT; Thor MG; Oates EC; van Karnebeek C; Hendson G; Blom E; Witting N; Rasmussen M; Gabbett MT; Ravenscroft G; Sframeli M; Suetterlin K; Sarkozy A; D'Argenzio L; Hartley L; Matthews E; Pitt M; Vissing J; Ballegaard M; Krarup C; Slørdahl A; Halvorsen H; Ye XC; Zhang LH; Løkken N; Werlauff U; Abdelsayed M; Davis MR; Feng L; Phadke R; Sewry CA; Morgan JE; Laing NG; Vallance H; Ruben P; Hanna MG; Lewis S; Kamsteeg EJ; Männikkö R; Muntoni F
    Brain; 2016 Mar; 139(Pt 3):674-91. PubMed ID: 26700687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle channelopathies and electrophysiological approach.
    Cherian A; Baheti NN; Kuruvilla A
    Ann Indian Acad Neurol; 2008 Jan; 11(1):20-7. PubMed ID: 19966974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Therapies for Skeletal Muscle Ion Channelopathies: Systematic Review and Steps Towards Precision Medicine.
    Desaphy JF; Altamura C; Vicart S; Fontaine B
    J Neuromuscul Dis; 2021; 8(3):357-381. PubMed ID: 33325393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands.
    Stunnenberg BC; Raaphorst J; Deenen JCW; Links TP; Wilde AA; Verbove DJ; Kamsteeg EJ; van den Wijngaard A; Faber CG; van der Wilt GJ; van Engelen BGM; Drost G; Ginjaar HB
    Neuromuscul Disord; 2018 May; 28(5):402-407. PubMed ID: 29606556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice with an NaV1.4 sodium channel null allele have latent myasthenia, without susceptibility to periodic paralysis.
    Wu F; Mi W; Fu Y; Struyk A; Cannon SC
    Brain; 2016 Jun; 139(Pt 6):1688-99. PubMed ID: 27048647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
    Al-Ghamdi F; Darras BT; Ghosh PS
    Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis.
    Jurkat-Rott K; Lehmann-Horn F
    Neurotherapeutics; 2007 Apr; 4(2):216-24. PubMed ID: 17395131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents.
    Jarecki BW; Piekarz AD; Jackson JO; Cummins TR
    J Clin Invest; 2010 Jan; 120(1):369-78. PubMed ID: 20038812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sodium channel knockin mutant (NaV1.4-R669H) mouse model of hypokalemic periodic paralysis.
    Wu F; Mi W; Burns DK; Fu Y; Gray HF; Struyk AF; Cannon SC
    J Clin Invest; 2011 Oct; 121(10):4082-94. PubMed ID: 21881211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison and functional study of the L703P: a recurrent mutation in human SCN4A that causes sodium channel myotonia.
    Ke Q; Zhao Y; Li Y; Ye J; Tang S; He F; Ji F; Dai X; Ni J; Li Y; Griggs RC; Cheng X
    Neuromuscul Disord; 2022 Oct; 32(10):811-819. PubMed ID: 36050252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia.
    Campanale C; Laghetti P; Saltarella I; Altamura C; Canioni E; Iosa E; Maggi L; Brugnoni R; Tacconi P; Desaphy JF
    J Neuromuscul Dis; 2024; 11(3):725-734. PubMed ID: 38427496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence study of genetically defined skeletal muscle channelopathies in England.
    Horga A; Raja Rayan DL; Matthews E; Sud R; Fialho D; Durran SC; Burge JA; Portaro S; Davis MB; Haworth A; Hanna MG
    Neurology; 2013 Apr; 80(16):1472-5. PubMed ID: 23516313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating phenotype and genotype in the periodic paralyses.
    Miller TM; Dias da Silva MR; Miller HA; Kwiecinski H; Mendell JR; Tawil R; McManis P; Griggs RC; Angelini C; Servidei S; Petajan J; Dalakas MC; Ranum LP; Fu YH; Ptácek LJ
    Neurology; 2004 Nov; 63(9):1647-55. PubMed ID: 15534250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Diversity of SCN4A-Mutation-Associated Skeletal Muscle Sodium Channelopathy.
    Lee SC; Kim HS; Park YE; Choi YC; Park KH; Kim DS
    J Clin Neurol; 2009 Dec; 5(4):186-91. PubMed ID: 20076800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies.
    Bissay V; Van Malderen SC; Keymolen K; Lissens W; Peeters U; Daneels D; Jansen AC; Pappaert G; Brugada P; De Keyser J; Van Dooren S
    Eur J Hum Genet; 2016 Mar; 24(3):400-7. PubMed ID: 26036855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.